Terms: = Lung cancer AND EPS15, AF-1P, 2060, ENSG00000085832, P42566, MLLT5, AF1P AND Treatment
30 results:
1. Patlak-Ki derived from ultra-high sensitivity dynamic total body [
Wang D; Qiu B; Liu Q; Xia L; Liu S; Zheng C; Liu H; Mo Y; Zhang X; Hu Y; Zheng S; Zhou Y; Fu J; Chen N; Liu F; Zhou R; Guo J; Fan W; Liu H
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3400-3413. PubMed ID: 37310427
[TBL] [Abstract] [Full Text] [Related]
2. treatment outcomes of stereotactic body radiation therapy for pulmonary metastasis from sarcoma: a multicenter, retrospective study.
Lee TH; Kim HJ; Kim JH; Kim MS; Jang WI; Kim E; Kim KS
Radiat Oncol; 2023 Apr; 18(1):68. PubMed ID: 37061679
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic significance of lung metastasis-related finding in lenvatinib treatment for differentiated thyroid cancer.
Yamazaki H; Iwasaki H; Masudo K; Toda S; Matsui A; Rino Y
Endocrine; 2022 Dec; 78(3):543-551. PubMed ID: 36070050
[TBL] [Abstract] [Full Text] [Related]
4. Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumors.
Semrad TJ; Kim EJ; Gong IY; Li T; Christensen S; Arora M; Riess JW; Gandara DR; Kelly K
Cancer Chemother Pharmacol; 2021 Aug; 88(2):335-341. PubMed ID: 33993383
[TBL] [Abstract] [Full Text] [Related]
5. Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases.
Kalinauskaite GG; Tinhofer II; Kufeld MM; Kluge AA; Grün AA; Budach VV; Senger CC; Stromberger CC
BMC Cancer; 2020 May; 20(1):404. PubMed ID: 32393261
[TBL] [Abstract] [Full Text] [Related]
6. Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness.
Goodman AM; Kato S; Chattopadhyay R; Okamura R; Saunders IM; Montesion M; Frampton GM; Miller VA; Daniels GA; Kurzrock R
Cancer Immunol Res; 2019 Jun; 7(6):866-873. PubMed ID: 31003990
[TBL] [Abstract] [Full Text] [Related]
7. Re-irradiation in locally recurrent lung cancer patients.
Schlampp I; Rieber J; Adeberg S; Bozorgmehr F; Heußel CP; Steins M; Kappes J; Hoffmann H; Welzel T; Debus J; Rieken S
Strahlenther Onkol; 2019 Aug; 195(8):725-733. PubMed ID: 30937509
[TBL] [Abstract] [Full Text] [Related]
8. Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers.
Hseu YC; Chang GR; Pan JY; Rajendran P; Mathew DC; Li ML; Liao JW; Chen WT; Yang HL
J Cell Physiol; 2019 Apr; 234(4):4125-4139. PubMed ID: 30146779
[TBL] [Abstract] [Full Text] [Related]
9. NF-κB-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers.
Wang X; Yin H; Zhang H; Hu J; Lu H; Li C; Cao M; Yan S; Cai L
Cell Death Dis; 2018 Apr; 9(4):418. PubMed ID: 29549343
[TBL] [Abstract] [Full Text] [Related]
10. [Clinical and Prognosic Anylasis of 30 Cases with Double Primary lung cancer].
Wang Z; Hou J; Wang H; Zhang G; Ma Z
Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):667-674. PubMed ID: 29061213
[TBL] [Abstract] [Full Text] [Related]
11. Hypermutations in gliomas: a potential immunotherapy target.
Finocchiaro G; Langella T; Corbetta C; Pellegatta S
Discov Med; 2017 Feb; 23(125):113-120. PubMed ID: 28371614
[TBL] [Abstract] [Full Text] [Related]
12. Mammalian eps15 homology domain 1 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition.
Meng Q; Xing Y; Ren T; Lu H; Xi Y; Jiang Z; Hu J; Li C; Sun L; Sun D; Cai L
Oncotarget; 2017 Apr; 8(14):22433-22442. PubMed ID: 27531895
[TBL] [Abstract] [Full Text] [Related]
13. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
Gao J; Meng Q; Zhao Y; Chen X; Cai L
BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
[TBL] [Abstract] [Full Text] [Related]
14. Critical airway obstruction: challenges in airway management and ventilation during therapeutic bronchoscopy.
Espinoza A; Neumann K; Halvorsen PS; Sundset A; Kongerud J; Fosse E
J Bronchology Interv Pulmonol; 2015 Jan; 22(1):41-7. PubMed ID: 25590482
[TBL] [Abstract] [Full Text] [Related]
15. Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study.
Cannon NA; Iyengar P; Choy H; Timmerman R; Meyer J
BMC Cancer; 2014 Dec; 14():971. PubMed ID: 25518879
[TBL] [Abstract] [Full Text] [Related]
16. Retinal metastasis from systemic cancer in 8 cases.
Shields CL; McMahon JF; Atalay HT; Hasanreisoglu M; Shields JA
JAMA Ophthalmol; 2014 Nov; 132(11):1303-8. PubMed ID: 25033168
[TBL] [Abstract] [Full Text] [Related]
17. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
Li J; Shi SB; Shi WL; Wang Y; Yu LC; Zhu LR; Ge LP
Transl Res; 2014 Jan; 163(1):27-35. PubMed ID: 24120632
[TBL] [Abstract] [Full Text] [Related]
18. BAI, a novel cyclin-dependent kinase inhibitor induces apoptosis in A549 cells through activation of caspases and inactivation of Akt.
Kim S; Lee J; Jang BC; Kwon TK; Park JW
J Cell Biochem; 2013 Feb; 114(2):282-93. PubMed ID: 22887215
[TBL] [Abstract] [Full Text] [Related]
19. Pharmacogenetics of EGFR in lung cancer: perspectives and clinical applications.
Mayo C; Bertran-Alamillo J; Molina-Vila MÁ; Giménez-Capitán A; Costa C; Rosell R
Pharmacogenomics; 2012 May; 13(7):789-802. PubMed ID: 22594511
[TBL] [Abstract] [Full Text] [Related]
20. Feasibility and effectiveness of inhaled carboplatin in NSCLC patients.
Zarogoulidis P; Eleftheriadou E; Sapardanis I; Zarogoulidou V; Lithoxopoulou H; Kontakiotis T; Karamanos N; Zachariadis G; Mabroudi M; Zisimopoulos A; Zarogoulidis K
Invest New Drugs; 2012 Aug; 30(4):1628-40. PubMed ID: 21739158
[TBL] [Abstract] [Full Text] [Related]
[Next]
